S&P 500 5,248.49 ▲ +0.42%
NASDAQ 16,402.18 ▲ +0.66%
DOW 39,127.84 ▼ −0.11%
US 10Y 4.21% ▼ −2bp
BTC $67,420 ▲ +1.28%
GOLD $2,341 ▲ +0.18%
USD/EUR 1.0824 ▼ −0.06%
VIX 13.42 ▼ −2.4%
OIL $82.16 ▲ +1.04%
DXY 104.21 ▲ +0.08%
S&P 500 5,248.49 ▲ +0.42%
NASDAQ 16,402.18 ▲ +0.66%
DOW 39,127.84 ▼ −0.11%
US 10Y 4.21% ▼ −2bp
BTC $67,420 ▲ +1.28%
GOLD $2,341 ▲ +0.18%
USD/EUR 1.0824 ▼ −0.06%
VIX 13.42 ▼ −2.4%
OIL $82.16 ▲ +1.04%
DXY 104.21 ▲ +0.08%
Latest› Regulation› Story
Regulation · June 22, 2026

Coca-Cola's $20B Transfer Pricing Battle Heads to Eleventh Circuit This Week

A decade-long dispute with the IRS over profit allocation could set a precedent for multinational tax enforcement.

Coca-Cola's $20B Transfer Pricing Battle Heads to Eleventh Circuit This Week Photo · James O'Connell for InvestLin

The Eleventh U.S. Circuit Court of Appeals in Miami is hearing arguments this week in a transfer pricing case that pits Coca-Cola against the Internal Revenue Service, with potential liabilities exceeding $20 billion. The dispute, rooted in tax returns from 2007 through 2009, centers on whether the beverage giant shifted too much profit to foreign subsidiaries to reduce its U.S. tax burden.

According to the Wall Street Journal, the case stems from a 1996 pricing agreement between Coca-Cola and the IRS. The company argues its intercompany transactions adhere to the arm's length standard, pricing deals as unrelated parties would. The IRS, however, contends that Coca-Cola underreported U.S. income by allocating excessive profits to affiliates in low-tax jurisdictions.

The stakes are enormous. A loss could saddle Coca-Cola with back taxes and interest exceeding its entire 2025 net income, plus a permanently higher tax rate. The company has already deposited $6 billion with the IRS during litigation, per Bloomberg Tax, which would be refunded if it wins. A defeat could add another $14 billion to the tab.

The IRS enters the appeal with momentum, having secured a complete victory in the original 2020 Tax Court ruling—a rare outcome against a major corporation. The case has spanned three Coca-Cola CEOs and 12 IRS leaders across both Republican and Democratic administrations, highlighting its longevity and complexity.

By the numbers
$20B
potential tax liability
$6B
deposited with IRS
2007-2009
tax years in dispute
2020
Tax Court ruling year

Gregory Garre, a former U.S. solicitor general, will argue for Coca-Cola on June 25 before a panel of two judges appointed by President Donald Trump and one by President Joe Biden. A decision could take months, and the losing side may seek review from the full appeals court or the Supreme Court.

The outcome carries broad implications for multinationals, particularly in technology and pharmaceuticals, where intellectual property frequently crosses borders. A Coca-Cola win would remove a financial cloud and offer relief to firms facing similar scrutiny. A defeat, however, could embolden the IRS to pursue aggressive transfer pricing adjustments.

For financial advisors, the case underscores the importance of monitoring regulatory shifts that affect corporate clients. As the Supreme Court and other courts reshape business landscapes, transfer pricing remains a critical risk factor for multinational portfolios.

The case also highlights the interplay between tax policy and corporate governance. Recent Delaware Chancery Court rulings on shareholder pay and governance statutes show how legal frameworks evolve, affecting advisor strategies. Similarly, this appeal could redefine how companies structure global operations.

As the hearing unfolds, advisors should watch for signals on tax enforcement trends. The IRS's rare Tax Court win suggests a tougher stance, but an appellate reversal could shift the landscape. Either way, the decision will ripple through corporate tax planning for years.

JO
About the author

James O'Connell

Regulation & Compliance Editor · Washington, D.C.

Covers the SEC, FINRA, DOL and state regulators from Washington, D.C.

Next story · Don't miss

Inspired Healthcare asset sale yields $713M, 59% of $1.2B raised from investors

Bankruptcy court approves sale of 30 properties, but investor recoveries remain uncertain amid fee disputes and arbitration hurdles.

Read the story →
Inspired Healthcare asset sale yields $713M, 59% of $1.2B raised from investors